These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19816786)

  • 41. A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine.
    Manis FR; Cohn LB; McBride-Chang C; Wolff JA; Kaufman FR
    J Inherit Metab Dis; 1997 Aug; 20(4):549-55. PubMed ID: 9266391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living.
    Iakovou K; Madoglou A; Monopolis I; Schulpis K
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):281-285. PubMed ID: 30730841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological and linguistic follow-up studies of children with galactosaemia from an unscreened population.
    Hansen TW; Henrichsen B; Rasmussen RK; Carling A; Andressen AB; Skjeldal O
    Acta Paediatr; 1996 Oct; 85(10):1197-201. PubMed ID: 8922083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychosocial aspects of PKU: hidden disabilities--a review.
    Gentile JK; Ten Hoedt AE; Bosch AM
    Mol Genet Metab; 2010; 99 Suppl 1():S64-7. PubMed ID: 20123473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship of genotype to cognitive outcome in galactosaemia.
    Shield JP; Wadsworth EJ; MacDonald A; Stephenson A; Tyfield L; Holton JB; Marlow N
    Arch Dis Child; 2000 Sep; 83(3):248-50. PubMed ID: 10952646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diet and visually significant cataracts in galactosaemia: is regular follow up necessary?
    Widger J; O'Toole J; Geoghegan O; O'Keefe M; Manning R
    J Inherit Metab Dis; 2010 Apr; 33(2):129-32. PubMed ID: 20151203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caregivers' nutrition-related knowledge, perceptions, practices and barriers regarding the therapeutic diet for classical galactosaemia.
    Blaauw GF; Dolman-Macleod RC; Van Niekerk E
    J Hum Nutr Diet; 2023 Aug; 36(4):1179-1192. PubMed ID: 36722740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.
    Waisbren S; White DA
    Mol Genet Metab; 2010; 99 Suppl 1():S96-9. PubMed ID: 20123479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White and gray matter brain development in children and young adults with phenylketonuria.
    Hawks Z; Hood AM; Lerman-Sinkoff DB; Shimony JS; Rutlin J; Lagoni D; Grange DK; White DA
    Neuroimage Clin; 2019; 23():101916. PubMed ID: 31491833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Young adult patients with a history of pediatric disease: impact on course of life and transition into adulthood.
    Stam H; Hartman EE; Deurloo JA; Groothoff J; Grootenhuis MA
    J Adolesc Health; 2006 Jul; 39(1):4-13. PubMed ID: 16781955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life of adult patients with hereditary fructose intolerance.
    Janssen LEF; Cassiman D; Brouwers MCGJ
    Mol Genet Metab; 2023 Nov; 140(3):107701. PubMed ID: 37757598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia).
    Ben Abdelaziz R; Ben Chehida A; Kachouri H; Ben Messaoud S; Ferchichi M; Ben Ameur Z; Sassi Y; Abdelmoula MS; Azzouz H; Tebib N
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):901-913. PubMed ID: 32639944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Living with classical galactosemia: health-related quality of life consequences.
    Bosch AM; Grootenhuis MA; Bakker HD; Heijmans HS; Wijburg FA; Last BF
    Pediatrics; 2004 May; 113(5):e423-8. PubMed ID: 15121984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia.
    Shakespeare L; Downing M; Allen J; Casbolt AM; Ellin S; Maloney M; Race G; Bonham J
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):567-9. PubMed ID: 20947531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Five years of screening for galactosaemia in South Africa: Pitfalls of using Benedict's test and thin layer chromatography to screen for galactosaemia in a developing country.
    Satekge TM; Kiabilua O; Krause A; Pillay TS
    Clin Chim Acta; 2020 Jun; 505():73-77. PubMed ID: 32092319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study.
    Waisbren SE; Hanley W; Levy HL; Shifrin H; Allred E; Azen C; Chang PN; Cipcic-Schmidt S; de la Cruz F; Hall R; Matalon R; Nanson J; Rouse B; Trefz F; Koch R
    JAMA; 2000 Feb; 283(6):756-62. PubMed ID: 10683054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychosocial developmental milestones in men with classic galactosemia.
    Gubbels CS; Maurice-Stam H; Berry GT; Bosch AM; Waisbren S; Rubio-Gozalbo ME; Grootenhuis MA
    J Inherit Metab Dis; 2011 Apr; 34(2):415-9. PubMed ID: 21350966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.